Carsten Thiel has built an impressive career in the pharmaceutical world. Carsten Thiel is an expert in biotechnology that has held a number of leadership positions. Currently he is the President of Europe for EUSA Pharma. Thiel has been responsible for multiple high-profile medical products which include Neulasta, Prolia and Vectibix. He has been instrumental in the change of many procedures that have made an impact on thousands of patients around the world.
Thiel success stems from his early start in Berlin, Germany. As a young man Thiel was very interested in chemistry and other sciences. He quickly learned that he had a unique talent for this area of study. This talent lead him to eventually go to school at the University of Bristol in the southwest of the UK. He had a desire to study at a traditional Anglo-Saxon school which lead him there. He earned his Bachelor of Science degree. He would soon go on to continue his education at the respected Max Planck Institute for Biophysical Chemistry. It was at this institution that Carsten Thiel would earn a Phd in Molecular Biology.
Carsten Thiel has been responsible for a number of major medical products. He is the creator of Xenical an innovative weight loss product. As a result of reasonable expectations the product received good success. Thiel would also go on to help create a cancer treatment known as Vectibix. Carsten Theil has used his expertise to promote excellent customer service. He has helped to change medical procedures that have impacted thousands of lives. Professionals in the pharmaceutical world look up to Thiel and emmulate his work.
Learn More: www.eusapharma.com/company/management-team/